Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
The Marygold Companies Reports Financial Results for Fiscal Year and Fourth Quarter Ended June 30, 2026
-
Cerebral Palsy Guide: Families of Children with CP Have More School Rights Than Many Ever Use
-
NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update
-
Mesa Royalty Trust Announces There Will Be No Distribution for September 2026
-
Birth Injury Justice Center: Delivery Records Often Show Whether Cerebral Palsy Was Preventable
-
Her Case Matters on Hair Relaxer Lawsuits: What You Need to Know in 2026
-
KKR Real Estate Finance Trust Inc. Declares Quarterly Dividend of $0.10 Per Share of Common Stock
-
Bank of America Declares Preferred Stock Dividends Payable in October and November 2026
-
Accenture and Anthropic Partner to Build Team of Embedded Evaluators at Anthropic
-
RiverNorth Opportunities Fund, Inc. Issues Mandatory Redeemable Preferred Shares
-
American Healthcare REIT Declares Third Quarter 2026 Distribution
-
Permianville Royalty Trust Announces Monthly Cash Distribution
-
Morningstar, Inc. Declares Quarterly Dividend of 50 Cents Per Share
-
Havertys Furniture Announces Participation in Sidoti Small-Cap Virtual Conference
-
Copper Property CTL Pass Through Trust Releases Q2-2026 Penney Intermediate Holdings LLC Financial Statements and Master Lease Store Performance Disclosures
-
Enact Receives Ratings Upgrade from AM Best
-
Omega Flex, Inc. Announces Regular Quarterly Dividend for the Third Quarter 2026
-
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
GreenPower Converts Series B Preferred Convertible Shares
-
Lung Cancer Group on Secondary Asbestos Exposure: Why Family Members Are at Risk of Lung Cancer
-
Broward Families to Receive Free Hurricane Supplies During Peak Hurricane Season
-
Best Crypto Presale: Why Apeing’s $0.0005 Entry Point is Grabbing Whales’ Interest While Solana Rebounds Past $105
-
DeFi Trading Activity Remains Volatile as Remittix Expands Beyond PayFi With Remittix Markets
-
NEAR Protocol Doubles in a Month as DigiTap Gives Retail a $0.0589 Entry Before the Wider Market Gets Its Turn
-
VerifyMe Declares Special Dividend
-
KBRA Assigns Rating to $250 Million Subordinated Notes Issued by Columbia Bank
-
for KING + COUNTRY Release Fifth Studio Album "the most beautiful colours"
-
for KING + COUNTRY Release Fifth Studio Album "the most beautiful colours"
-
Okta Names Helen Riley to Board of Directors
-
Apogee Enterprises Completes Acquisition of GroGlass
-
QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board
-
Huntington Bancshares Incorporated Declares Cash Dividend On Its Series I Preferred Stock
-
Phoenix Energy Announces Distribution for Preferred Shares
-
Saratoga Investment Corp. Announces CFO Transition and New Leadership Appointments
-
HF Foods Group Announces Termination of At-The-Market Equity Offering Program
-
XCharge Reports First Half 2026 Unaudited Financial Results
-
LOBO TECHNOLOGIES LTD. Announces First Half of Fiscal Year 2026 Financial Results
-
Nscale Files Registration Statement for Proposed Initial Public Offering
-
/C O R R E C T I O N -- Mood Fabrics/
-
McGrath Declares Quarterly Dividend
-
Kroger to Host 2026 Investor Day on October 20, 2026
-
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Amneal Announces FDA Approval and Launch of Lanreotide Injection
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Silver Tiger Announces Results of Annual and Special Meeting
-
Coming Home Project and Birds Eye View Project Complete Groundbreaking Ayahuasca Retreat for Veterans
-
United Church of God to assemble for fall global festival, celebrate coming time of Christ-centered peace
-
Lainey Wilson, Jelly Roll and Lukas Nelson Share Their Songs and Stories at All for the Hall Los Angeles with Special Guest John Mayer
-
Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot Ulcers
-
Latham Expands Market-Leading Antitrust & Competition Practice with Paris Partner Victor Levy
